Immunomodulation via paracrine signaling and immune cell interaction

"Immunomodulation via paracrine signaling and immune cell interaction" refers to a broad biological process rather than a discrete molecular target. It encompasses how immune cells communicate with each other through locally secreted factors—primarily cytokines and chemokines—that act on neighboring cells to coordinate immune responses. This form of cell-to-cell communication is essential for activating and regulating both innate and adaptive immunity. Key examples include T cells releasing interleukin-2 (IL-2) to stimulate proliferation of nearby T cells or macrophages secreting tumor necrosis factor alpha (TNF-α) during inflammation. Dysregulation of this system contributes significantly to diseases such as rheumatoid arthritis, cancer (via effects on the tumor microenvironment), metabolic disorders like insulin resistance in obesity, autoimmune conditions, and chronic inflammatory states. While many therapeutics target components within these pathways—for example, monoclonal antibodies against TNF-alpha—the term itself does not denote a single druggable entity but rather describes an overarching mechanism involving multiple molecular players. Drugs do not target this overall process directly but rather specific molecules within these pathways, such as TNF inhibitors like etanercept for TNF-alpha. Mechanism of action is defined for drugs targeting individual cytokines or receptors involved in these pathways—e.g., cytokine inhibition—but not for the broad process itself. Biomarkers are typically specific to individual mediators, such as IL-6 or TNF-alpha, not to the general concept of paracrine immunomodulation. Safety concerns relate to targeting specific mediators within these pathways; for example, risk of infection with anti-cytokine therapies. This entry is considered incorrect as a therapeutic "target" because it does not refer to any one molecule or receptor but instead describes an entire class of cellular interactions mediated by numerous distinct proteins and signaling molecules. For structured data purposes, this should be mapped either onto its constituent molecular targets (such as "Interleukin 6 receptor," "Tumor necrosis factor alpha," etc.) or classified under broader biological processes rather than listed as an individual druggable target.

Other names

Paracrine immunomodulationImmune cell paracrine interactionParacrine signaling in immunityImmune cell cross-talk via paracrine factors